Global Cell Dissociation Market By Product Type (Enzymatic Dissociation Products (Collagenase, Trypsin, Papain, Elastase, DNase, Hyaluronidase, Others) and Instruments), By Tissue (Connective Tissues, Epithelial Tissues and Others) Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Key Highlights of the Report

How are the major segments performing in the cell dissociation market?

• In 2022, the enzymatic dissociation products category accounted for the largest share of the market. Enzymes are used to break down the fragments of tissue that were broken up, releasing the tissue’s cells. The dissociation process makes use of a variety of enzymes, some of which can be combined.
• In 2022, the sporting goods chain category held the largest share as cell-based research and development gained popularity in the pharmaceutical and biotechnology sectors.
• In 2022, the tissue dissociation category held the largest share. This market is expected to rise due to factors like the biopharmaceutical and pharmaceutical industries’ increased focus on creating monoclonal antibodies and the individualization of medical care.
• In 2022, the pharmaceutical companies category accounted for the largest share of the market. Cell dissociation enzymes are widely used in pharmaceuticals, so this category has a large share and is expanding quickly.

What is the market size of cell dissociation regarding value?

The global cell dissociation market is anticipated to grow at a substantial CAGR of 18.20% in the upcoming years. The global Cell dissociation industry was estimated to be worth USD 518.6 billion in 2022 and was expected to be worth USD 1671.7 billion by 2028.

Which region dominated the cell dissociation market?

In 2022, the North American region was anticipated to hold a prominent share in the global cell dissociation market as chronic illnesses like cancer are rising. Throughout the anticipated year, the region’s cell dissociation market will grow due to the entry of significant key players and the expanding industrial and academic interest in research and development in biosciences. Developing a cure for several chronic illnesses, including cancer, is also supported financially through money given to several regional enterprises.

How is the US market performing in the cell dissociation market?

In 2022, the United States was anticipated to hold a prominent share of the global cell dissociation market in the North American region. The incidence of cancer and other chronic illnesses is expected to increase throughout the forecast period. Other factors contributing to this prediction include the strong trend of the industry and academic R&D investments in the life sciences, as well as acquisitions and collaborations by the top market players in the country. In 2021, there was anticipated that there would be 1,898,160 new cancer cases and 608,570 cancer-related deaths in the United States.

How is the economy impacting global cell dissociation growth?

The COVID-19 pandemic has significantly impacted global hospital resources. It has mostly been accomplished by dramatically reducing inpatient and outpatient care for various illnesses and implementing infection prevention and control measures. When the epidemic spread to all nations, the frequency of cancer screenings and diagnostic procedures drastically decreased. As a result, the market would experience a growth spurt throughout the forecast period.

What is the competitive environment of the cell dissociation market?

To increase their market position, major firms are using various techniques, such as introducing novel products, partnerships, collaborations, mergers & acquisitions, and geographic growth. For instance, in February 2020, S2 Genomics unveiled the Singulator 100 System. The System facilitates the conversion of solid tissue samples into suspensions of nuclei or single cells with high yields and from tiny samples for a variety of genomic studies and single-cell biology. The apparatus makes it simple for researchers to reliably produce suspensions of excellent, highly viable nuclei or cells with minimal variation. It standardises the procedure for separating solid tissues.

Executive Summary

What are the key trends in the cell dissociation market?

• In stem cell research, the application of cell dissociation techniques has grown significantly. Because dissociated cells are frequently employed to produce induced pluripotent stem cells (iPSCs) and other cell types for research and clinical uses, this is fuelling market expansion.
• The market is expanding due to increased R&D expenditures by biopharmaceutical businesses. Because it is directly involved in medication development and the understanding of pathophysiology, cell dissociation is a crucial activity in biopharmaceutical research. With significant consequences for healthcare, the pharmaceutical industry’s biopharmaceutical sector is expanding quickly. Opportunities in biopharmaceuticals have increased over the past ten years due to these medicines’ great efficacy and safety.

How has the rise of recombinant therapies made from mammalian cells affected the expansion of the cell dissociation market?

The proportion of recombinant treatments made from mammalian cells in the biopharmaceutical industry has significantly increased since 2002. An average of 8.5% more recombinant products from mammalian cell culture were approved between 2002 and 2022. As of June 2022, more than 300 recombinant products were on the market, indicating a rapid transition to treatments based on mammals, which will account for nearly 67% of all therapies that year. The sector’s advancement depends on creating mammalian-based recombinant medicines, including cell dissociation.

Which are the key investments by the cell dissociation market players?

Major companies in the biopharmaceutical sector are concentrating on R&D in several therapeutic areas to commercialize novel medications. These companies accomplish this, among other things, by making significant investments in clinical trials, efficacy research, and toxicity studies. Most of this study isolates cells from primary tissues using tissue dissociation products. For instance, the pharmaceutical industry invested $83 billion in research and development in 2019. Between 2010 and 2019, the number of new medications permitted for sale increased by 60% compared to the prior decade, peaking at 59 new drugs approved in 2018.

Some major players in the cell dissociation market are VitaCyte, LLC, Thermo Fisher Scientific Inc., PAN-Biotech, Merck KGaA, HiMedia Laboratories, Miltenyi Biotec GmbH, STEMCELL Technologies Inc., General Electric Company, Roche Diagnostics, Becton, Dickinson and Company.

What are the major driving factors for the cell dissociation market?

The rising demand for R&D in biopharmaceutical firms is one of the key factors anticipated to drive the growth of the cell dissociation market during the forecast period. The favourable funding environment for cancer research and the increasing incidence and prevalence of infectious and chronic diseases are also expected to contribute to the market for cell dissociation’s growth. Furthermore, it is anticipated that the increasing emphasis on individualized care and the rise in government funding for cell-based research may impede the expansion of the cell dissociation industry. In the upcoming years, there may be further prospects for expanding the cell dissociation market due to the expanding prospect in developing markets and the rise in the produced tissue dissociation enzyme products.

What are the major risks for the cell dissociation market?

The high cost of tissue and cell-based procedures, the preference for enzyme-free over enzymatic dissociation products, ethical restraints regarding the use of cell-based research, a lack of infrastructure for cell-based research in developing regions, and others are some of the factors that are predicted to restrain the market during the forecast period. Cell dissociation market expansion, however, may face further difficulties in the near future due to the presence of minor competitors and new entrants.

Which is the key product type category in the cell dissociation market?

The enzymatic dissociation products category held the largest share of the market in 2022. The main uses of enzymes in stem cell and cell biology research are cell dissociation, primary cell separation, and single-cell harvesting. Enzymes are frequently used in cell dissociation processes. Any dissociation method should aim to produce as many functionally viable dissociated cells as possible. Each dissociation procedure’s outcome depends on various factors, including the kind of tissue, the age of the animal or human, the dissociation medium, the enzyme utilized, its concentration, temperature, and genetic changes. As a result, a variety of enzymes are utilized in research projects for a variety of reasons.

How is the cell dissociation market performing in regions?

Asia Pacific market is anticipated to witness the fastest growth in the global cell dissociation market during the forecast period because the demand for innovative medicines is growing. Some important elements driving the regional market’s growth include escalating government R&D expenditures and swift infrastructure development. A treatment for numerous chronic diseases, such as cancer, is also being developed by several local businesses with funding. For instance, Immuneel Therapeutics was given a budget of USD 15 million in June 2022 to provide cost-effective cell and gene therapy for cancer patients in India.

What is the regulatory landscape for the cell dissociation market?

Growing government and corporate support for stem cell research are projected to create new business prospects for the sector. For instance, the California Institute for Regenerative Medicine awarded the City of Hope a USD 4.9 million grant in March 2022. With the financing, the Research Center will be better able to mentor the subsequent generation of scientific pioneers in stem cell study and its application to cutting-edge, life-saving therapies. The awards will help scientists conduct laboratory research, develop cell-based medicines, create and produce cells, obtain regulatory approval, and biomedical market goods.

What are the major players planning for the future of the cell dissociation market?

The need for cell dissociation solutions is expected to increase due to the growing interest in personalized and regenerative medicine. Cell dissociation is a crucial step in which the patient’s genetic makeup is assessed to decide the best course of action. Cell dissociation materials are used to create cell-based therapeutics and regenerative medicine solutions. The market for cell dissociation products is projected to increase as chronic and infectious diseases become more prevalent. Cancer, Alzheimer’s disease, and diabetes are just some illnesses that can be detected and treated using cell-based tests. Technological developments in cell dissociation products are driving the market’s revenue. Applications in research and development could grow if reagents and kits that offer effective cell dissociation become more widely available.

Segmentation of Global Cell Dissociation Market-

Global Cell Dissociation Market – By Product Type

• Enzymatic Dissociation Products
• Collagenase
• Trypsin
• Papain
• Elastase
• DNase
• Hyaluronidase
• Others
• Instruments

Global Cell Dissociation Market – By Tissue

• Connective Tissues
• Epithelial Tissues
• Others

Global Cell Dissociation Market – By Dissociation

• Tissue Dissociation
• Cell Detachment

Global Cell Dissociation Market – By End User

• Biotechnology Companies
• Pharmaceutical Companies
• Academic Institutes
• Research Institutes

Global Cell Dissociation Market – By Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • South-east Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa